Selected research
Industry Research
Injectable Hyaluronic Acid Dermal Filler Industry Research Report 2026
Market perspective
The global Injectable Hyaluronic Acid Dermal Filler market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Injectable Hyaluronic Acid Dermal Filler is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Injectable Hyaluronic Acid Dermal Filler is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Injectable Hyaluronic Acid Dermal Filler is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Injectable Hyaluronic Acid Dermal Filler include Bloomage BioTechnology, Huadong Medicine, Haohai Biological Technology, Teoxane, NovaCutis, Merz, LG Corporation, Hugel and Galderma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Injectable Hyaluronic Acid Dermal Filler market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Injectable Hyaluronic Acid Dermal Filler Market by Company
Bloomage BioTechnology
Huadong Medicine
Haohai Biological Technology
Teoxane
NovaCutis
Merz
LG Corporation
Hugel
Galderma
Bohus BioTech
BioScience GmbH
BioPlus
AbbVie
Injectable Hyaluronic Acid Dermal Filler Segment by Type
Monophasic Filler
Multiphasic Filler
Injectable Hyaluronic Acid Dermal Filler Segment by Application
Beauty Agency
Hospital
Injectable Hyaluronic Acid Dermal Filler Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Hyaluronic Acid Dermal Filler market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Injectable Hyaluronic Acid Dermal Filler and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Hyaluronic Acid Dermal Filler.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Injectable Hyaluronic Acid Dermal Filler manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Injectable Hyaluronic Acid Dermal Filler by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Injectable Hyaluronic Acid Dermal Filler in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Monophasic Filler
- Multiphasic Filler
Applications
- Beauty Agency
- Hospital
Companies covered
- Bloomage BioTechnology
- Huadong Medicine
- Haohai Biological Technology
- Teoxane
- NovaCutis
- Merz
- LG Corporation
- Hugel
- Galderma
- Bohus BioTech
- BioScience GmbH
- BioPlus
- AbbVie
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Injectable Hyaluronic Acid Dermal Filler Market Size (2021-2032)
- 2.2.2 Global Injectable Hyaluronic Acid Dermal Filler Sales (2021-2032)
- 2.2.3 Global Injectable Hyaluronic Acid Dermal Filler Market Average Price (2021-2032)
- 2.3 Injectable Hyaluronic Acid Dermal Filler by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Monophasic Filler
- 2.3.3 Multiphasic Filler
- 2.4 Injectable Hyaluronic Acid Dermal Filler by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Beauty Agency
- 2.4.3 Hospital
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Injectable Hyaluronic Acid Dermal Filler Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Injectable Hyaluronic Acid Dermal Filler Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Injectable Hyaluronic Acid Dermal Filler Revenue of Manufacturers (2021-2026)
- 3.4 Global Injectable Hyaluronic Acid Dermal Filler Average Price by Manufacturers (2021-2026)
- 3.5 Global Injectable Hyaluronic Acid Dermal Filler Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Injectable Hyaluronic Acid Dermal Filler, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Injectable Hyaluronic Acid Dermal Filler, Product Type & Application
- 3.8 Global Manufacturers of Injectable Hyaluronic Acid Dermal Filler, Established Date
- 3.9 Global Injectable Hyaluronic Acid Dermal Filler Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bloomage BioTechnology
- 4.1.1 Bloomage BioTechnology Company Information
- 4.1.2 Bloomage BioTechnology Business Overview
- 4.1.3 Bloomage BioTechnology Injectable Hyaluronic Acid Dermal Filler Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bloomage BioTechnology Injectable Hyaluronic Acid Dermal Filler Product Portfolio
- 4.1.5 Bloomage BioTechnology Recent Developments
- 4.2 Huadong Medicine
- 4.2.1 Huadong Medicine Company Information
- 4.2.2 Huadong Medicine Business Overview
- 4.2.3 Huadong Medicine Injectable Hyaluronic Acid Dermal Filler Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Huadong Medicine Injectable Hyaluronic Acid Dermal Filler Product Portfolio
- 4.2.5 Huadong Medicine Recent Developments
- 4.3 Haohai Biological Technology
- 4.3.1 Haohai Biological Technology Company Information
- 4.3.2 Haohai Biological Technology Business Overview
- 4.3.3 Haohai Biological Technology Injectable Hyaluronic Acid Dermal Filler Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Haohai Biological Technology Injectable Hyaluronic Acid Dermal Filler Product Portfolio
- 4.3.5 Haohai Biological Technology Recent Developments
- 4.4 Teoxane
- 4.4.1 Teoxane Company Information
- 4.4.2 Teoxane Business Overview
- 4.4.3 Teoxane Injectable Hyaluronic Acid Dermal Filler Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teoxane Injectable Hyaluronic Acid Dermal Filler Product Portfolio
- 4.4.5 Teoxane Recent Developments
- 4.5 NovaCutis
- 4.5.1 NovaCutis Company Information
- 4.5.2 NovaCutis Business Overview
- 4.5.3 NovaCutis Injectable Hyaluronic Acid Dermal Filler Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 NovaCutis Injectable Hyaluronic Acid Dermal Filler Product Portfolio
- 4.5.5 NovaCutis Recent Developments
- 4.6 Merz
- 4.6.1 Merz Company Information
- 4.6.2 Merz Business Overview
- 4.6.3 Merz Injectable Hyaluronic Acid Dermal Filler Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Merz Injectable Hyaluronic Acid Dermal Filler Product Portfolio
- 4.6.5 Merz Recent Developments
- 4.7 LG Corporation
- 4.7.1 LG Corporation Company Information
- 4.7.2 LG Corporation Business Overview
- 4.7.3 LG Corporation Injectable Hyaluronic Acid Dermal Filler Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 LG Corporation Injectable Hyaluronic Acid Dermal Filler Product Portfolio
- 4.7.5 LG Corporation Recent Developments
- 4.8 Hugel
- 4.8.1 Hugel Company Information
- 4.8.2 Hugel Business Overview
- 4.8.3 Hugel Injectable Hyaluronic Acid Dermal Filler Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hugel Injectable Hyaluronic Acid Dermal Filler Product Portfolio
- 4.8.5 Hugel Recent Developments
- 4.9 Galderma
- 4.9.1 Galderma Company Information
- 4.9.2 Galderma Business Overview
- 4.9.3 Galderma Injectable Hyaluronic Acid Dermal Filler Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Galderma Injectable Hyaluronic Acid Dermal Filler Product Portfolio
- 4.9.5 Galderma Recent Developments
- 4.10 Bohus BioTech
- 4.10.1 Bohus BioTech Company Information
- 4.10.2 Bohus BioTech Business Overview
- 4.10.3 Bohus BioTech Injectable Hyaluronic Acid Dermal Filler Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bohus BioTech Injectable Hyaluronic Acid Dermal Filler Product Portfolio
- 4.10.5 Bohus BioTech Recent Developments
- 4.11 BioScience GmbH
- 4.11.1 BioScience GmbH Company Information
- 4.11.2 BioScience GmbH Business Overview
- 4.11.3 BioScience GmbH Injectable Hyaluronic Acid Dermal Filler Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 BioScience GmbH Injectable Hyaluronic Acid Dermal Filler Product Portfolio
- 4.11.5 BioScience GmbH Recent Developments
- 4.12 BioPlus
- 4.12.1 BioPlus Company Information
- 4.12.2 BioPlus Business Overview
- 4.12.3 BioPlus Injectable Hyaluronic Acid Dermal Filler Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 BioPlus Injectable Hyaluronic Acid Dermal Filler Product Portfolio
- 4.12.5 BioPlus Recent Developments
- 4.13 AbbVie
- 4.13.1 AbbVie Company Information
- 4.13.2 AbbVie Business Overview
- 4.13.3 AbbVie Injectable Hyaluronic Acid Dermal Filler Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 AbbVie Injectable Hyaluronic Acid Dermal Filler Product Portfolio
- 4.13.5 AbbVie Recent Developments
5 Global Injectable Hyaluronic Acid Dermal Filler Market Scenario by Region
- 5.1 Global Injectable Hyaluronic Acid Dermal Filler Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Injectable Hyaluronic Acid Dermal Filler Sales by Region: 2021-2032
- 5.2.1 Global Injectable Hyaluronic Acid Dermal Filler Sales by Region: 2021-2026
- 5.2.2 Global Injectable Hyaluronic Acid Dermal Filler Sales by Region: 2027-2032
- 5.3 Global Injectable Hyaluronic Acid Dermal Filler Revenue by Region: 2021-2032
- 5.3.1 Global Injectable Hyaluronic Acid Dermal Filler Revenue by Region: 2021-2026
- 5.3.2 Global Injectable Hyaluronic Acid Dermal Filler Revenue by Region: 2027-2032
- 5.4 North America Injectable Hyaluronic Acid Dermal Filler Market Facts & Figures by Country
- 5.4.1 North America Injectable Hyaluronic Acid Dermal Filler Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Injectable Hyaluronic Acid Dermal Filler Sales by Country (2021-2032)
- 5.4.3 North America Injectable Hyaluronic Acid Dermal Filler Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Injectable Hyaluronic Acid Dermal Filler Market Facts & Figures by Country
- 5.5.1 Europe Injectable Hyaluronic Acid Dermal Filler Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Injectable Hyaluronic Acid Dermal Filler Sales by Country (2021-2032)
- 5.5.3 Europe Injectable Hyaluronic Acid Dermal Filler Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Injectable Hyaluronic Acid Dermal Filler Market Facts & Figures by Country
- 5.6.1 Asia Pacific Injectable Hyaluronic Acid Dermal Filler Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Injectable Hyaluronic Acid Dermal Filler Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Injectable Hyaluronic Acid Dermal Filler Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Injectable Hyaluronic Acid Dermal Filler Market Facts & Figures by Country
- 5.7.1 South America Injectable Hyaluronic Acid Dermal Filler Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Injectable Hyaluronic Acid Dermal Filler Sales by Country (2021-2032)
- 5.7.3 South America Injectable Hyaluronic Acid Dermal Filler Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Injectable Hyaluronic Acid Dermal Filler Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Injectable Hyaluronic Acid Dermal Filler Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Injectable Hyaluronic Acid Dermal Filler Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Injectable Hyaluronic Acid Dermal Filler Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Injectable Hyaluronic Acid Dermal Filler Sales by Type (2021-2032)
- 6.1.1 Global Injectable Hyaluronic Acid Dermal Filler Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Injectable Hyaluronic Acid Dermal Filler Sales Market Share by Type (2021-2032)
- 6.2 Global Injectable Hyaluronic Acid Dermal Filler Revenue by Type (2021-2032)
- 6.2.1 Global Injectable Hyaluronic Acid Dermal Filler Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Injectable Hyaluronic Acid Dermal Filler Revenue Market Share by Type (2021-2032)
- 6.3 Global Injectable Hyaluronic Acid Dermal Filler Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Injectable Hyaluronic Acid Dermal Filler Sales by Application (2021-2032)
- 7.1.1 Global Injectable Hyaluronic Acid Dermal Filler Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Injectable Hyaluronic Acid Dermal Filler Sales Market Share by Application (2021-2032)
- 7.2 Global Injectable Hyaluronic Acid Dermal Filler Revenue by Application (2021-2032)
- 7.2.1 Global Injectable Hyaluronic Acid Dermal Filler Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Injectable Hyaluronic Acid Dermal Filler Revenue Market Share by Application (2021-2032)
- 7.3 Global Injectable Hyaluronic Acid Dermal Filler Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Injectable Hyaluronic Acid Dermal Filler Value Chain Analysis
- 8.1.1 Injectable Hyaluronic Acid Dermal Filler Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Injectable Hyaluronic Acid Dermal Filler Production Mode & Process
- 8.2 Injectable Hyaluronic Acid Dermal Filler Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Injectable Hyaluronic Acid Dermal Filler Distributors
- 8.2.3 Injectable Hyaluronic Acid Dermal Filler Customers
9 Global Injectable Hyaluronic Acid Dermal Filler Analyzing Market Dynamics
- 9.1 Injectable Hyaluronic Acid Dermal Filler Industry Trends
- 9.2 Injectable Hyaluronic Acid Dermal Filler Industry Drivers
- 9.3 Injectable Hyaluronic Acid Dermal Filler Industry Opportunities and Challenges
- 9.4 Injectable Hyaluronic Acid Dermal Filler Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst